Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

By Kimball Alexa B.  

American Journal of Clinical Dermatology, Vol. 12, Iss. 1, 2011-02 ,pp. : 51-62

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Desloratadine in Adults with Chronic Idiopathic Urticaria: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

By Ortonne Jean-Paul  

American Journal of Clinical Dermatology, Vol. 8, Iss. 1, 2007-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of the Betamethasone Valerate 0.1% Plaster in Mild-to-Moderate Chronic Plaque Psoriasis: A Randomized, Parallel-Group, Active-Controlled, Phase III Study

By Naldi Luigi  

American Journal of Clinical Dermatology, Vol. 12, Iss. 3, 2011-06 ,pp. : 191-201

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of a Cosmetically Acceptable Coal Tar Solution in the Treatment of Moderate Plaque Psoriasis: A Controlled Comparison with Calcipotriene (Calcipotriol) Cream

By Alora-Palli Maria B.  

American Journal of Clinical Dermatology, Vol. 11, Iss. 4, 2010-08 ,pp. : 275-283

Adis International

Access to resources Recommend Favorite

Efficacy of Topical Tacrolimus 0.1% in Active Plaque Morphea: Randomized, Double-Blind, Emollient-Controlled Pilot Study

By Kroft Elisabeth B.M.   Groeneveld Tamara J.   Seyger Marieke M.B.   de Jong Elke M.G.J.  

American Journal of Clinical Dermatology, Vol. 10, Iss. 3, 2009-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite